Theromics Revenue and Competitors
Estimated Revenue & Valuation
- Theromics's estimated annual revenue is currently $1.7M per year.
- Theromics's estimated revenue per employee is $130,769
- Theromics's total funding is $3.4M.
Employee Data
- Theromics has 13 Employees.
- Theromics grew their employee count by 86% last year.
Theromics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder & Chief Medical Officer | Reveal Email/Phone |
3 | C.E.O. | Reveal Email/Phone |
Theromics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 242 | 28% | N/A | N/A |
#2 | $7.5M | 14 | 0% | N/A | N/A |
#3 | N/A | 10 | 25% | N/A | N/A |
#4 | N/A | 4 | -20% | N/A | N/A |
#5 | N/A | 18 | 20% | N/A | N/A |
#6 | $7.5M | 99 | 3% | N/A | N/A |
#7 | $7.5M | 72 | 33% | N/A | N/A |
#8 | N/A | 17 | 55% | N/A | N/A |
#9 | N/A | 5 | 67% | N/A | N/A |
#10 | N/A | 10 | 0% | N/A | N/A |
What Is Theromics?
Theromics has developed a novel, safe, Thermal Accelerant (TA) called HeatSYNC TA. The HeatSYNC TA is used during microwave and radiofrequency ablations of cancerous tumors. HeatSYNC can augment the reach of thermal energy from a distance normally unattainable by microwave or radiofrequency devices, thus high-power energy is not needed. “Caution: This device is for Investigational Use Only and has not been cleared by the FDA or other regulatory bodies.”
keywords:N/A$3.4M
Total Funding
13
Number of Employees
$1.7M
Revenue (est)
86%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.5M | 23 | 21% | N/A |
#2 | $4.7M | 25 | 0% | N/A |
#3 | $4M | 25 | 0% | N/A |
#4 | $10M | 31 | 11% | N/A |
#5 | $7.4M | 32 | 3% | N/A |